Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published online as doi:10.1189/jlb.1102528 on May 20, 2004

Published online before print May 20, 2004
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1102528v1
76/2/352    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baker, W.
Right arrow Articles by Cannon, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baker, W.
Right arrow Articles by Cannon, J. G.
(Journal of Leukocyte Biology. 2004;76:352-358.)
© 2004 by Society for Leukocyte Biology

P-selectin inhibition suppresses muscle regeneration following injury

Wallace Baker*,1, Barbara A. St. Pierre Schneider*,1, Anhurunda Kulkarni*, Gloria Sloan{dagger}, Robert Schaub{ddagger}, Joseph Sypek{ddagger} and Joseph G. Cannon{dagger},2

{dagger} Departments of Medical Technology and Physiology, Medical College of Georgia, Augusta;
* Noll Physiological Research Center, Pennsylvania State University, University Park; and
{ddagger} Wyeth Research, Andover, Massachusetts

2Correspondence: School of Allied Health Sciences, AA-2028, Medical College of Georgia, 1120 15th Street, Augusta, GA 30912-0100. E-mail: jcannon{at}mcg.edu


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
This investigation sought to determine if P-selectin-mediated mechanisms contributed to macrophage localization in damaged muscle, an essential process for muscle regeneration. Mice were injected intravenously (i.v.) with soluble P-selectin glycoprotein ligand-1 (sPSGL-1) at 5, 50, or 200 µg/mouse or with 100 µl vehicle alone, and then, lengthening contractions were induced in hindlimb plantar-flexor muscles. The contractions caused fiber damage in soleus muscles, with maximal invasion by CD11b+ mononuclear cells at 24 h post-injury and substantial accumulation of CD11b+ mononuclear cells in the extracellular matrix up to 7 days post-injury. sPSGL-1 treatment caused a dose-dependent decrease in the number of regenerating fibers (P=0.021), as determined by developmental myosin heavy chain (dMHC) expression. This expression was reduced 93% at 7 days post-injury by the highest dose of sPSGL-1, which had no significant influence on intrafiber or extracellular accumulation of cells expressing CD11b, a general marker for phagocytic cells. Additional mice were injected i.v. with 20 µg anti-P-selectin or isotype-control immunoglobulin G and were then subjected to lengthening contractions as before. At 7 days post-injury, soleus muscles from anti-P-selectin-treated mice contained 48% fewer mononuclear cells that bound ER-BMDM1 (P=0.019), a marker for mature macrophages and dendritic cells, and 84% fewer fibers expressing dMHC (P = 0.006), compared with muscles from isotype-injected, control mice. The number of CD11b+ cells was not significantly different between groups. The results are consistent with the concept that P-selectin is involved in the recruitment, maturation, and/or activation of cells that are critical for muscle fiber regeneration.

Key Words: macrophage • satellite cell • dendritic cell • myotube


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Skeletal muscle contains an intrinsic population of quiescent precursor (satellite) cells that are induced to proliferate and differentiate, leading to muscle fiber regeneration following damage [1 ]. In addition, experimental evidence suggests that extrinsic cells are also necessary [2 ]. Several studies have demonstrated that muscle regeneration following injury is inhibited if the experimental animals are first irradiated to suppress hematopoiesis [3 4 5 ]. These results have been interpreted as evidence that recruitment of marrow-derived, blood-borne cells to the site of injury is an essential component of the regeneration process. Leukocytes comprise a major proportion of the cells arriving at the site. The phagocytic activity of neutrophils and macrophages is considered to be important for clearing damaged tissue [2 ]. Moreover, in vitro studies have shown that macrophages produce factors that are chemotactic and mitogenic for satellite cells and fibroblasts [6 , 7 ]. Nevertheless, establishing a causal role for these cells in vivo using radiation may be confounded by deleterious effects of radiation on systemic metabolism, endocrine function, or local satellite cell viability.

Rather than eliminate blood-cell formation, the present study sought to block cell homing to damaged muscle. The first step in this process involves the selectin family of adhesion molecules. One member of this family, P-selectin, appears to be functional in skeletal muscle vasculature [8 , 9 ]. P-selectin is stored in endothelial cell granules and can be expressed rapidly on the luminal surface in response to stimuli such as thrombin or histamine. Surface P-selectin binds a cognate ligand on leukocytes, P-selectin glycoprotein ligand-1 (PSGL-1). Transient, successive P-selectin-binding events mediate the transition of leukocyte movement from free flow to rolling along the endothelium. This brings the leukocytes in contact with chemokines, which in turn activate integrins, the adhesion molecules that form the anchor points for leukocyte extravasation between endothelial cells into the tissue [10 ]. In the present study, soluble PSGL-1 (sPSGL-1) was injected intravenously (i.v.) before muscle damage to saturate P-selectin and prevent rolling and subsequent extravasation of cells into the damaged muscle tissue. P-selectin function was also inhibited in alternative experiments by injecting a monoclonal antibody specific for murine P-selectin.

Previous studies of macrophage-mediated regeneration have used invasive methods for inducing muscle damage such as crushing exposed muscle with forceps [4 ] or grafting minced muscle into surgically produced cavities in extant muscle [5 ]. An alternative, in vivo method used in the present study induced damage in murine skeletal muscle by lengthening contractions [11 ]. This mechanical stimulus causes limited, well-tolerated muscle fiber damage with a significant influx of macrophages within 24 h [12 , 13 ]. Fibers undergoing regeneration recapitulate developmental isoforms of myosin heavy chain (dMHC) with expression detectable immunohistochemically by 3 days post-injury [12 ]. The contraction-induced damage induced in the present study represents a mild, physiologically relevant model of injury that is not confounded by surgical stress or local infection.

The purpose of this study was to test the hypothesis that interfering with P-selectin-mediated adherence would reduce the influx of blood-borne cells into damaged muscle and as a result, inhibit muscle regeneration. If P-selectin were to be identified as a specific control point in the extravasation process, which is critical to muscle regeneration, it would represent a target for future therapeutic interventions directed at muscle trauma and disease.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Animals
Male, C57BL/6J mice (Jackson Laboratory, Bar Harbor, ME) were housed one per cage in animal quarters maintained at 23°C with a 12:12-h light-dark cycle. Water and rodent food were provided ad libitum. All protocols involving sPSGL-1 were approved by the Institutional Animal Care and Use Committee of Pennsylvania State University (University Park). In later studies using anti-P-selectin, male ICR mice (Harlan, Indianapolis, IN) were used according to protocols approved by the Institutional Animal Care and Use Committee of the Medical College of Georgia (Augusta).

Immediately before the contraction protocol, mice were anesthetized by inhalation of methoxyflurane and then injected with a recombinant sPSGL-1 expressed in COS cells [14 ] (I316, Wyeth Research, Andover, MA) at doses of 50 or 200 µg/mouse in phosphate-buffered saline (PBS) with 1% bovine serum albumin (BSA; Sigma Chemical Co.) or PBS/BSA vehicle alone via lateral tail vein. A limited number of experiments were performed using 5 µg/mouse, as described in Results. Vehicle was used as a control for sPSGL-1, as the low-affinity form of sPSGL-1 [15 ] was not available in sufficient quantities at the time of these studies. In later experiments, anti-P-selectin (553741, BD PharMingen, San Diego, CA) or isotype control (559157, BD PharMingen) was delivered via lateral tail vein at a dose of 20 µg in 100 µl PBS.

Lengthening contraction-induced damage
Ashton-Miller et al. [11 ] developed the protocol used in these studies. Percutaneous electrodes were inserted posterior of the midpoint of the left femur (near the tibial nerve). The left foot was strapped into a shoe, and the left knee was stabilized by an adjustable bar. Muscle contraction was stimulated by 400-ms pulses at 150 Hz and 4 V, one stimulation every 2 s for three 5-min periods (total=450 contractions). The shoe was attached to a servomotor (Model 300B, Cambridge Technology, Watertown, MA), which rotated the ankle joint from a neutral (90°) position to a dorsiflexed position (+36°) during the final 200-ms of each stimulation. Each 5-min stimulation period was followed by a 5-min rest period during which time the anesthetized mouse remained immobilized in the apparatus. A Macintosh Quadra 650 computer, GW Instruments analog/digital interface board, and Superscope II software (GW Instruments, Somerville, MA) were used to control the servomotor and collect data. Animals recovered from anesthesia within 1 h and survived until the time of sacrifice. Normal daily activities were not impaired following the muscle damage protocol.

Tissue processing
Groups of mice (n=4–6 mice/dose/time-point, unless otherwise indicated) were killed after 1, 3, 5, and 7 days after injury (with some additional sampling at 1, 3, 6, 12, and 15 h in some experiments). At the time of sacrifice, eccentrically loaded soleus muscles were dissected out of the hind limbs of all animals, and contralateral control solei were sampled from a subset of animals as described in Results. Muscles were rinsed with sterile saline, embedded (OCT, Miles, Naperville IL), frozen in isopentane cooled to the temperature of liquid nitrogen, and transferred to polypropylene containers for storage at –70°C.

Morphological staining and immunohistochemistry
Serial, transverse, 10 µm sections were cut from the midsections of all muscles using a cryostat (Cryocut 1800, Reichert-Jung/Leica, Nussloch, Germany) maintained at –20°C. The sections were applied to poly-L-lysine-coated glass slides (Sigma Chemical Co.). Immunohistochemical staining was conducted using rat anti-mouse CD11b (M1/70, BD PharMingen), rat anti-mouse ER-BMDM1 (Accurate Chemical and Scientific, Westbury, NY), rat anti-mouse 7/4 (Serotec, Raleigh, NC), rat anti-mouse P-selectin (RB40.34, BD PharMingen), and anti-dMHC (RNMY2/9D2, Novocastra Laboratories Ltd., Newcastle, UK). For this procedure, sections were fixed in acetone, blocked with 2% BSA in PBS (pH 7.5), and then rinsed in PBS. The primary antibodies were diluted to optimum concentrations (1:20–1:500) in PBS. Tissue sections were incubated with primary antibody in a humidified chamber for 3 h, rinsed in PBS, and incubated with the secondary antibody, biotinylated goat anti-rat immunoglobulin G (IgG; Vector Laboratories, Burlingame, CA), diluted 1:200, for 1 h in a humidified chamber. Endogenous peroxidase activity was quenched by immersing the slides in 0.3% hydrogen peroxide in methanol for 20 min. Slides were rinsed, then incubated for 30 min with Vectastain ABC peroxidase reagent (Vector Laboratories), rinsed, and then incubated with 3,3'-diaminobenzidine (Sigma Chemical Co.) for 8 min. The sections were dehydrated in 95% and 100% ethanol, cleared with Hemo De (Fisher Scientific, Pittsburgh, PA), and mounted under glass coverslips with nonaqueous medium (Cytoseal, VWR, West Chester, PA). Sections incubated in PBS in the absence of primary antibody served as controls. Some sections were fixed in methanol and then stained with hematoxylin and eosin (H&E) for morphological analysis.

Myeloperoxidase (MPO) activity
Frozen sections were thawed, dried, and then immersed in acetone for 10 min, followed by 8 min in PBS. The sections were then blotted, and a drop of True Blue peroxidase substrate solution (Kirkegaard and Perry, Gaithersburg, MD) was applied to each section and allowed to react for 5 min. The sections were rinsed in distilled water, then dehydrated, cleared, and mounted as described above.

Myoblast cultures
C2C12 myoblasts (American Type Culture Collection, Manassas, VA) were cultured in 10 cm polystyrene dishes (Corning, NY) in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, 100 µg/ml streptomycin, and 0.2 mM L-glutamine (all from Sigma Chemical Co.) until achieving 100% confluence. Differentiation was induced by substituting 5% horse serum for the FBS. At this time, recombinant sPSGL-1 (Wyeth Research) was added to achieve final concentrations of 0.1, 1.0, and 10 µg/ml. An equivalent volume of media alone was added to control cultures. The cells were incubated at 37°C in an atmosphere of 5% CO2 and assessed for differentiation into myotubes with an inverted microscope periodically (every 6–12 h) for 72 h.

Data analysis
All slides were coded and then analyzed without knowledge of sample identity. Three outcome variables were assessed in this study. Invaded fibers: Myofibers containing CD11b+ cells well within their borders were classified as "invaded". The total number of invaded fibers in the entire cross-section was counted and reported as a percentage of the total fiber number. Cellular densities in the perimysium and endomysium [i.e., extracellular matrix (ECM)]: The densities of CD11b+ and ER-BMDM1+ cells were determined by counting cells in a 0.0625-mm2 field (encompassing ~36 fibers) using an ocular grid. As the muscle damage was focal in nature, the areas of greatest density in the cross-section were selected. Three to five fields were analyzed, and the highest count was reported, expressed per mm2. Cells with segmented nuclei, 7/4+ cells, and MPO activity were counted over the entire cross-section and were expressed per mm2. Muscle cross-sectional areas were determined on images captured with a Sony CCD camera linked to a Macintosh G3 computer using National Institutes of Health Image software. The number of myofibers in the entire section that expressed dMHC was classified as "regenerating myofibers" and was reported as a percentage of the total fiber number: We have published photomicrographs of these features in damaged murine skeletal muscle in previous reports [12 , 13 ]. Data throughout are presented as mean ± SE. dMHC data were normalized by log transformation. ANOVA was performed using SuperANOVA software (Abacus Concepts, Berkeley, CA). Post-hoc analyses of differences between groups were conducted using Fisher’s protected least significant difference test.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Uninjured, contralateral muscles were removed from animals at 1, 3, 5, and 7 days (n=3 at each time, except n=2 at day 5), sectioned, and stained for CD11b. These sections rarely contained invaded myofibers (zero or one per section, which was less than 0.002% of the total fibers in the section, which numbered 862±31). The maximal density of CD11b+ cells in the ECM was 25 ± 5 cells/mm2. Twelve uninjured, contralateral control muscles taken at 7 days were sectioned and stained for dMHC. Regenerating fibers were also rare in these contralateral controls (zero or one per section).

In the damaged muscle, the number of fibers invaded by CD11b+ mononuclear cells was maximal 1 day after injury (8±3 fibers/section or 0.66±0.28%; Fig. 1 ). Myofibrillar invasion diminished over time and resolved by 7 days post-injury. sPSGL-1 had no significant influence on the number of fibers invaded with CD11b+ cells (P>0.8). Accumulation of CD11b+ cells in the ECM reached maximal, focal densities of ~200 cells/mm2 by 24 h post-injury. These cells remained evident throughout the 7 days of observation, gradually declining in number over time. sPSGL-1 treatment had no significant influence on extracellular density of CD11b+ cells (P>0.4; Fig. 2 ).



View larger version (21K):
[in this window]
[in a new window]
  		Figure 1. Percentage of muscle fibers invaded by CD11b+ mononuclear cells following contraction-induced damage. No significant differences were observed among vehicle-injected controls (solid bars) or mice injected i.v. with 50 µg (open bars) or 200 µg sPSGL-1 (hatched bars). Sample size = four to six mice per group, except 200 µg at 5 days; n = 2.

 


View larger version (30K):
[in this window]
[in a new window]
  		Figure 2. Density of CD11b+ cells in the ECM of soleus muscle following contraction-induced damage. Bar designations and sample sizes are the same as in Figure 1 . Two outliers (>5 standard deviations above the group means)—one in the 50 µg, 5-day group and the other in the 200 µg, 7-day group—were not included in the data plotted in Figure 3 so that the bars present an unskewed visualization of trends. No significant differences were observed between vehicle and sPSGL-1-treated animals regardless of whether the outliers were included or excluded from statistical analysis.

 
In previous work involving extensive H&E staining of muscle sections taken from 1 to 10 days after damage, we rarely observed PMNs [12 ]. To determine if a very early influx of neutrophils (which might be influenced by sPSGL-1) was missed by the sampling schedules of the previous and present study, additional mice were subjected to the lengthening contraction protocol and then sampled at 1, 3, 6, 12, 15, and 24 h; then, transverse muscle sections were examined for cells with the characteristic, segmented nuclei of neutrophils, as well as expression of surface antigen 7/4 and MPO activity. As shown in Figure 3 , very few cells exhibited segmented nuclei. Numbers of cells expressing 7/4 did not change significantly (P=0.12), whereas cells expressing MPO did increase (P=0.0004). Although neutrophils express 7/4 and MPO, the lack of cells with segmented nuclei suggests that 7/4 and MPO staining is probably attributable to monocytes [16 ], although no double-staining was conducted to confirm this supposition.



View larger version (19K):
[in this window]
[in a new window]
  		Figure 3. Number of cells expressing MPO, antigen 7/4, or exhibiting segmented nuclei [polymorphonuclear neutrophil (PMN)] in soleus muscle within the first 24 h following contraction-induced injury. Only MPO showed a statistically significant increase over time (P=0.0004). Sample size = four animals per time-point except at 15 h; n = 2.

 
The regenerative characteristics of damaged muscle following treatment with sPSGL-1 were next assessed. Immunohistochemical staining for dMHC clearly identified fibers undergoing regeneration. Pretreatment with sPSGL-1 caused a dose-dependent reduction in the number of dMHC+ fibers assessed at 3, 5, and 7 days (P=0.021; Fig. 4 ). Developmental MHC is rarely observed as early as 1 day [12 ] and therefore was not assessed in this study. An additional group of mice was pretreated with 5 µg sPSGL-1 to delineate further the effective dose range. These mice were assessed at 7 days post-injury, the time of maximal dMHC expression. This lower dose resulted in a 51% reduction of mean dMHC expression (1.82±1.60% of total fibers compared with 3.74±1.43% in vehicle-treated, control mice), but this was not a statistically significant difference (Fig. 5 ). Both higher doses reduced dMHC expression to less than 0.4% of total fibers (P<0.03; Fig. 5 ).



View larger version (17K):
[in this window]
[in a new window]
  		Figure 4. Number of myofibers expressing dMHC. One outlier was omitted from the 50 µg, day-5 group, as the value was >10 standard deviations above the group mean. A dose-dependent inhibition of dMHC expression by sPSGL-1 was observed across all time-points, regardless of whether the outlier was in included (P=0.021) or excluded (P=0.003) from statistical analysis. Bar designations and sample sizes are the same as Figure 1 .

 


View larger version (13K):
[in this window]
[in a new window]
  		Figure 5. Dose-response for sPSGL-1 inhibition of dMHC expression by myofibers at 7 days post-injury. Sample size = six for all groups except vehicle control (0 µg sPSGL-1); n = 5. *, P < 0.03, compared with vehicle control.

 
sPSGL-1 influenced regeneration but had no apparent effect on CD11b+ cell infiltration; therefore, we explored the possibility that sPSGL-1 might act directly on muscle cells. This was approached in two ways. In the first approach, muscle sections from vehicle-treated controls (one from each time-point except 15 h) were stained with anti-P-selectin to determine if this adhesion molecule was expressed within the muscle fibers themselves. Weak, positive staining was observed on vascular endothelium (data not shown), but no evidence of P-selectin was found by light microscopy elsewhere at any time. In the second approach, C2C12 myoblasts were incubated with concentrations of PSGL-1 ranging from 0.1 to 10 µg/ml to determine if differentiation into myotubes was influenced. This range of ligand concentrations was patterned after the effective doses reported for P-selectin-induced tissue-factor expression on monocytes in vitro [17 ]. No differences were observed between control cultures and any of the PSGL-1-treated cultures (data not shown).

To verify that the observed changes in dMHC were a result of inhibition of P-selectin, additional mice were injected i.v. with 20 µg anti-P-selectin or isotype-control IgG. The plantarflexor muscles were subjected to lengthening contractions and then were removed at 7 days post-injury along with uninjured, contralateral control muscles. Mononuclear cells were characterized in the muscles using ER-BMDM1, which recognizes mature macrophages and dendritic cells (DC). As shown in Figure 6 , the maximal focal densities of ER-BMDM1+ cells in the injured muscles from anti-P-selectin-treated mice were approximately half that in isotype-treated controls (197±41 per mm2 vs. 377±83 per mm2, P=0.019). The undamaged, contralateral control muscles had significantly lower ER-BMDM1+ cell densities than the injured muscles (135±13 per mm2, P=0.008). Developmental MHC was expressed in 4.14 ± 1.53% of the fibers of injured soleus muscle from isotype-injected mice, but only 0.68 ± 0.27% of the fibers in muscle from anti-P-selectin-injected mice (P=0.006). Maximal focal densities of CD11b+ cells were not significantly different in damaged muscles from anti-P-selectin versus isotype-treated mice (150±44 vs. 143±19 cells/mm2, P=0.83) but were significantly higher than uninjured, contralateral control muscles (29±5 cells/mm2, P<0.0001).



View larger version (12K):
[in this window]
[in a new window]
  		Figure 6. Maximal focal density of cells expressing ER-BMDM1 (left panel) and percent of fibers expressing dMHC (right panel) at 7 days after contraction-induced injury. The contralateral soleus muscles were not subjected to contractions. Shaded bars, Isotype-treated, control mice; n = 7. Solid bars, Mice treated with 20 µg anti-P-selectin; n = 6. *, P<0.02, compared with isotype control.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
The lengthening contraction protocol used in this investigation caused mild damage to murine soleus muscles, resulting in 0.66% of the fibers becoming invaded with CD11b+ cells and an eightfold increase in the density of CD11b+ cells in the peri- and endomysial spaces surrounding these fibers. By 7 days following the injury, ~4% of the fibers expressed dMHC, indicating active myofiber regeneration. Injection (i.v.) of sPSGL-1 immediately before the muscle-contraction protocol inhibited subsequent muscle regeneration in a dose-dependent manner. Anti-P-selectin also significantly inhibited dMHC expression and reduced the accumulation of ER-BMDM1+ cells. These results are consistent with the concept that mononuclear cells are critical for muscle regeneration, and these cells require the P-selectin adhesion system for homing to or activation in the damaged tissue. Macrophages secrete factors that are chemotactic and mitogenic for muscle precursor cells, as described in the Introduction. Furthermore, macrophages are important sources of the enzymes responsible for protein catabolism in skeletal muscle following blunt trauma [18 ] and are sources of fibronectin, which contributes to ECM repair [19 ].

Macrophages typically express CD11b, but the maximal density of CD11b+ mononuclear cells observed infiltrating the muscle was not significantly affected by P-selectin inhibition. In contrast, anti-P-selectin treatment reduced the maximal density of cells reacting with ER-BMDM1, an antibody that recognizes a 160-kDa aminopeptidase associated with the plasma membranes of mature macrophages and DC [20 ]. In previous studies, we found that cells expressing this antigen were significantly increased in muscle 5–7 days after injury [13 ]. The reduced focal densities of ER-BMDM1+ cells but not CD11b+ cells in the present study suggest that P-selectin may selectively recruit a population of monocytes already committed to a particular maturation pathway, or alternatively, P-selectin directly influences monocyte maturation and function. In vitro experiments have shown that P-selectin binding stimulates monocyte expression of tissue factor [17 ], interleukin-1 receptor type II, and insulin-like growth factor-I [21 ]. It also modulates macrophage phagocytosis [22 ] and expression of surface antigens associated with DC [23 ].

Pimorady-Esfahani and co-workers [24 ] have identified a population of putative DC expressing MHC class II, which accumulates in crush-injured tibialis anterior muscle over a time-course independent of CD11b+ accumulation. Some subclasses of DC do not express CD11b [25 ] but do express PSGL-1 [26 ] and therefore may be influenced by P-selectin. Matrix degradation products [27 ] and necrotic cells [28 ] can activate DC to produce cytokines that modulate the response to injury.

It is possible that P-selectin could influence other types of cells implicated in muscle regeneration. Ferrari and co-workers [29 ] reported that marrow-derived cells can be recruited from the bloodstream and become incorporated into regenerating tibialis anterior muscle after cardiotoxin-induced damage. Primitive marrow-derived precursor cells express PSGL-1 [30 ] and thus may represent another class of cells whose migration into damaged muscle may have been affected by P-selectin inhibition.

The role of P-selectin has been investigated in other models of tissue damage and wound repair. By pretreating rats with the same sPSGL-1 formulation used in the present study, Dulkanchainun et al. [31 ] reduced neutrophil infiltration and hepatic injury significantly following ischemia/reperfusion. Similarly, Wang et al. [32 ] demonstrated that pretreating dogs with a PSGL-1–Ig chimera before ischemia/reperfusion reduced neutrophil influx as well as myocardial injury. A substantial portion of the damage following ischemia/reperfusion is thought to be mediated by neutrophils; hence, these two studies confirm that blocking neutrophil influx reduces tissue injury. In contrast, the damage resulting from the present lengthening-contraction model had no neutrophil involvement, as shown in Figure 3 and reported previously by Lapointe et al. [33 ].

In another study, PSGL–Ig pretreatment of rats had no influence on histology or tensile strength development during the healing process following surgical incisions of the skin [34 ] (in contrast to the reduced muscle regeneration observed in the present paper). Different tissues and types of wounds may require different healing mechanisms. For example, E-selectin is an important adhesion molecule in the skin [35 ] but is not constitutively expressed in skeletal muscle nor is it induced in skeletal muscle by local application of antigen [9 ] or cytokines [36 ].

The observed CD11b+ cellular infiltration into skeletal muscle in the present study suggests that P-selectin-independent recruitment mechanisms were functioning. These results are consistent with the observation that macrophage recruitment into damaged skeletal muscle is maintained in mice deficient in P- and E-selectins [37 ]. L-selectin-mediated adhesion has been demonstrated in muscle [38 , 39 ]. Furthermore, mononuclear cell recruitment can be mediated by integrins in the absence of selectins [40 ].

In conclusion, inhibition of P-selectin caused significant reductions in myofiber regeneration following contraction-induced muscle damage. Although differences in CD11b+ cellular infiltration into damaged muscle were not detected, significant reductions in ER-BMDM1+ cells were observed. The results are consistent with the concept that P-selectin is involved in the extravasation, development, and/or activation of cells that are critical for muscle fiber repair. Identification of interventions that enhance P-selectin function and macrophage/DC development may lead to new treatments for acute muscle injury and degenerative muscle diseases.


   ACKNOWLEDGEMENTS
 
This work was supported by Wyeth Research and the Medical College of Georgia Research Institute (to J. G. C.), a National Institutes of Health Postdoctoral Fellowship to B. A. S. P. S. (NR07097), and a Pennsylvania State University Kinesiology Graduate Assistantship to W. B. We thank Crista Royal for technical assistance and Dr. Lynnette McCluskey for helpful advice and use of her cryostat.


   FOOTNOTES
 
1 These authors contributed equally to this work and should be considered co-first authors. Back

Received November 5, 2002; revised April 8, 2004; accepted April 9, 2004.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Bischoff, R. (1994) The satellite cell and muscle regeneration Engel, A. G. Franzini-Armstrong, C. eds. Myology ,97-118 McGraw-Hill New York, NY.
  2. Carlson, B. M., Faulkner, J. A. (1983) The regeneration of skeletal muscle fibers following injury: a review Med. Sci. Sports Exerc. 15,187-198[CrossRef][Medline]
  3. Dmitrieva, E. V. (1960) Post-traumatic regeneration of skeletal type musculature under total and local X-irradiation Arkh. Anat. Gistol. Embriol. 39,11-22
  4. Robertson, T. A., Grounds, M. D., Papadimitriou, J. M. (1992) Elucidation of aspects of murine skeletal muscle regeneration using local and whole body irradiation J. Anat. 181,265-276
  5. Lescaudron, L., Peltekian, E., Fontaine-Perus, J., Paulin, D., Zampieri, M., Garcia, L., Parrish, E. (1999) Blood-borne macrophages are essential for the triggering of muscle regeneration following muscle transplant Neuromuscul. Disord. 9,72-80[CrossRef][Medline]
  6. Robertson, T. A., Maley, M. A. L., Grounds, M. D., Papadimitriou, J. M. (1993) The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis Exp. Cell Res. 207,321-331[CrossRef][Medline]
  7. Cantini, M., Massimino, M. L., Bruson, A., Cantini, C., Libera, L. D., Carraro, U. (1994) Macrophages regulate proliferation and differentiation of satellite cells Biochem. Biophys. Res. Commun. 202,1688-1696[CrossRef][Medline]
  8. Nolte, D., Schmid, P., Jager, U., Botzlar, A., Roesken, F., Hecht, R., Uhl, E., Messmer, K., Vestweber, D. (1994) Leukocyte rolling in venules of striated muscle and skin is mediated by P-selectin, not by L-selectin Am. J. Physiol. 267,H1637-H1642
  9. Hickey, M. J., Kanwar, S., McCafferty, D-M., Granger, D. N., Eppihimer, M. J., Kubes, P. (1999) Varying roles of E-selectin and P-selectin in different microvascular beds in response to antigen J. Immunol. 162,1137-1143[Abstract/Free Full Text]
  10. Springer, T. A. (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm Cell 76,301-314[CrossRef][Medline]
  11. Ashton-Miller, J. A., He, Y., Kadhiresan, V. A., McCubbrey, D. A., Faulkner, J. A. (1992) An apparatus to measure in vivo biomechanical behavior of dorsi- and plantarflexors of mouse ankle J. Appl. Physiol. 72,1205-1211[Abstract/Free Full Text]
  12. Keller, H. L., St. Pierre Schneider, B., Eppihimer, L. A., Cannon, J. G. (1999) Association of IGF-1 and IGF-II with myofiber regeneration in vivo Muscle Nerve 22,347-354[CrossRef][Medline]
  13. St. Pierre Schneider, B., Correia, L. A., Cannon, J. G. (1999) Sex differences in leukocyte invasion in injured murine skeletal muscle Res. Nurs. Health 22,243-250[CrossRef][Medline]
  14. Sako, D., Chang, X-J., Barone, K. M., Vachino, G., White, H. M., Shaw, G., Veldman, G. M., Bean, K. M., Ahern, T. J., Furie, B., Cumming, D. A., Larsen, G. R. (1993) Expression cloning of a functional glycoprotein ligand for P-selectin Cell 75,1179-1186[CrossRef][Medline]
  15. Hayward, R., Campbell, B., Shin, Y. K., Scalia, R., Lefer, A. M. (1999) Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats Cardiovasc. Res. 41,65-76[Abstract/Free Full Text]
  16. Gordon, S., Lawson, L., Rabinowitz, S., Crocker, P. R., Morris, L., Perry, V. H. (1992) Antigen markers of macrophage differentiation in murine tissues Curr. Top. Microbiol. Immunol. 181,1-32[Medline]
  17. Celi, A., Pellegrini, G., Lorenzet, R., Blasi, A. D., Ready, N., Furie, B. C., Furie, B. (1994) P-selectin induces the expression of tissue factor on monocytes Proc. Natl. Acad. Sci. USA 91,8767-8771[Abstract/Free Full Text]
  18. Farges, M-C., Balcerzak, D., Fisher, B. D., Attaix, D., Bechet, D., Ferrara, M., Baracos, V. E. (2002) Increased muscle proteolysis after local trauma mainly reflects macrophage-associated lysosomal proteolysis Am. J. Physiol. Endocrinol. Metab. 282,E326-E335[Abstract/Free Full Text]
  19. Brown, L. F., Dubin, D., Lavinge, L., Logan, B., Dvorak, D. F., Van De Water, L. (1993) Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing Am. J. Pathol. 142,793-801[Abstract]
  20. Leenen, P. J. M., Melis, M., Kraal, G., Hoogeveen, A. T., Van Ewijk, W. (1992) The monoclonal antibody ER-BMDM1 recognizes a macrophage and dendritic cell differentiation antigen with aminopeptidase activity Eur. J. Immunol. 22,1567-1572[Medline]
  21. Mahoney, T. S., Weyrich, A. S., Dixon, D. A., McIntyre, T., Prescott, S. M., Zimmerman, G. A. (2001) Cell adhesion regulates gene expression at translational checkpoints in human myeloid leukocytes Proc. Natl. Acad. Sci. USA 98,10284-10289[Abstract/Free Full Text]
  22. Elstad, M. R., La Pine, T. R., Cowley, F. S., McEver, R. P., McIntyre, T. M., Prescott, S. M., Zimmerman, G. A. (1995) P-selectin regulates platelet-activating factor synthesis and phagocytosis by monocytes J. Immunol. 155,2109-2122[Abstract]
  23. Li, G., Kim, Y-J., Mantel, C., Broxmeyer, H. E. (2003) P-selectin enhances generation of CD14+CD16+ dendritic-like cells and inhibits macrophage maturation from human peripheral blood monocytes J. Immunol. 171,669-677[Abstract/Free Full Text]
  24. Pimorady-Esfahani, A., Grounds, M. D., McMenamin, P. G. (1997) Macrophages and dendritic cells in normal and regenerating murine skeletal muscle Muscle Nerve 20,158-166[CrossRef][Medline]
  25. Lipscomb, M. F., Masten, B. J. (2002) Dendritic cells: immune regulators in health and disease Physiol. Rev. 82,97-130[Abstract/Free Full Text]
  26. Laszik, Z., Jansen, P. J., Cummings, R. D., Tedder, T. F., McEver, R. P., Moore, K. L. (1996) P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells Blood 88,3010-3021[Abstract/Free Full Text]
  27. Termeer, C. C., Hennies, J., Voith, U., Ahrens, T., Weiss, J. M., Prehm, P., Simon, J. C. (2000) Oligosaccharides of hyaluronan are potent activators of dendritic cells J. Immunol. 165,1863-1870[Abstract/Free Full Text]
  28. Gallucci, S., Lolkema, M., Matzinger, P. (1999) Natural adjuvants: endogenous activators of dendritic cells Nat. Med. 5,1249-1255[CrossRef][Medline]
  29. Ferrari, G., Cusella-De Angelis, G., Coletta, M., Paolucci, E., Stornaiolo, A., Cossu, G., Mavilio, F. (1998) Muscle regeneration by bone marrow-derived myogenic progenitors Science 279,1528-1530[Abstract/Free Full Text]
  30. Zannettino, A. C. W., Berndt, M. C., Butcher, C., Butcher, E. C., Vadas, M. A., Simmons, P. J. (1995) Primitive human hematopoietic progenitors adhere to P-selectin (CD62) Blood 85,3466-3477[Abstract/Free Full Text]
  31. Dulkanchainun, T. S., Goss, J. A., Imagawa, D. K., Shaw, G. D., Anselmo, D. M., Kaldas, F., Wang, T., Zhao, D., Busuttil, A. A., Kato, H., Murray, N. G. B., Kupiec-Weglinski, J. W., Busuttil, R. W. (1998) Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1 Ann. Surg. 227,832-839[CrossRef][Medline]
  32. Wang, K., Zhou, X., Zhou, Z., Tarakji, K., Qin, J. X., Sitges, M., Shiota, T., Forudi, F., Schaub, R. G., Kumar, A., Penn, M. S., Topol, E. J., Lincoff, A. M. (2002) Recombinant soluble P-selectin glycoprotein ligand-Ig (rPSGL-Ig) attenuates infarct size and myeloperoxidase activity in a canine model of ischemia-reperfusion Thromb. Haemost. 88,149-154[Medline]
  33. Lapointe, B. M., Frenette, J., Cote, C. H. (2002) Lengthening contraction-induced inflammation is linked to secondary damage but devoid of neutrophil invasion J. Appl. Physiol. 92,1995-2004[Abstract/Free Full Text]
  34. Myers, D. D., Jr, Linn, M. J., Hawley, A. E., Mell, A. G., Hughes, R. E., Philbrick, B. G., Knipp, B. S., Wrobleski, S. K., Chapman, A. M., Wakefield, T. W., Schaub, R. G. (2002) The effects of P-selectin receptor antagonist rPSGL-Ig on wound healing in a rodent model Wounds: Comp. Clin. Res. Pract. 14,244-251
  35. Subramaniam, M., Saffaripour, S., Van De Water, L., Frenette, P. S., Mayadas, T. N., Hynes, R. O., Wagner, D. D. (1997) Role of endothelial selectins in wound repair Am. J. Pathol. 150,1701-1709[Abstract]
  36. Thorlacius, H., Lindbom, L., Raud, J. (1997) Cytokine-induced leukocyte rolling in mouse cremaster muscle arterioles is P-selectin-dependent Am. J. Physiol. 272,H1725-H1729
  37. Frenette, J., Chbinou, N., Godbout, C., Marsolais, D., Frenette, P. S. (2003) Macrophages, not neutrophils, infiltrate skeletal muscle in mice deficient in P/E selectins after mechanical reloading Am. J. Physiol. Regul. Integr. Comp. Physiol. 285,R727-R732[Abstract/Free Full Text]
  38. Lozano, D. D., Kahl, E. A., Wong, H. P., Stephenson, L. L., Zamboni, W. A. (1999) L-selectin and leukocyte function in skeletal muscle reperfusion injury Arch. Surg. 134,1079-1081[Abstract/Free Full Text]
  39. Hickey, M. J., Forster, M., Mitchell, D., Kaur, J., De Caigny, C., Kubes, P. (2000) L-selectin facilitates emigration and extravascular locomotion of leukocytes during acute inflammatory responses in vivo J. Immunol. 165,7164-7170[Abstract/Free Full Text]
  40. Hickey, M. J., Granger, D. N., Kubes, P. (1999) Molecular mechanisms underlying IL-4-induced leukocyte recruitment in vivo: a critical role for the {alpha}4 integrin J. Immunol. 163,3441-3448[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 FASEB J.Home page
L. Pelosi, C. Giacinti, C. Nardis, G. Borsellino, E. Rizzuto, C. Nicoletti, F. Wannenes, L. Battistini, N. Rosenthal, M. Molinaro, et al.
Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines
FASEB J, May 1, 2007; 21(7): 1393 - 1402.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
P. K. Shireman, V. Contreras-Shannon, O. Ochoa, B. P. Karia, J. E. Michalek, and L. M. McManus
MCP-1 deficiency causes altered inflammation with impaired skeletal muscle regeneration
J. Leukoc. Biol., March 1, 2007; 81(3): 775 - 785.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1102528v1
76/2/352    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baker, W.
Right arrow Articles by Cannon, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baker, W.
Right arrow Articles by Cannon, J. G.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS